SCM
PRQR icon

Sterling Capital Management’s ProQR Therapeutics PRQR Stock Holding History

Sterling Capital Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,611
Closed -$52K – 988
2016
Q1 		$52K Hold
10,611
– – ﹤0.01% 897
2015
Q4 		$92K Sell
10,611
-300
-3% -$3.45K ﹤0.01% 965
2015
Q3 		$159K Buy
+10,911
New +$183K ﹤0.01% 930
2015
Q2 		– Sell
-12,000
Closed -$280K – 926
2015
Q1 		$280K Sell
12,000
-2,672
-18% -$55.2K ﹤0.01% 799
2014
Q4 		$318K Sell
14,672
-4,708
-24% -$71.5K ﹤0.01% 830
2014
Q3 		$333K Buy
+19,380
New +$311K ﹤0.01% 803

Other funds holding PRQR

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sterling Capital Management's PRQR Position: Q2 2016 in Review

Sterling Capital Management sold out of ProQR Therapeutics (PRQR) in Q2 2016, closing a stake of 10,611 shares — an estimated $52K sold.

Sterling Capital Management first reported a position in PRQR in Q3 2014 and held it in 6 quarters. The position peaked at $333K in Q3 2014. 26 funds tracked by Wall St. Rank hold PRQR as of Q2 2016.

  • Sterling Capital Management reported no remaining ProQR Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Sterling Capital Management sold 10,611 ProQR Therapeutics shares in Q2 2016, an estimated $52K.
  • Sterling Capital Management first reported a position in ProQR Therapeutics in Q3 2014 and held it in 6 quarters.
  • Sterling Capital Management's ProQR Therapeutics position peaked at $333K in Q3 2014.
  • 26 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2016.

Based on Sterling Capital Management's 13F filing for Q2 2016, filed 19 Aug 2016.